Allogeneic SCT was introduced in the treatment of multiple myeloma (MM) 25 years ago, yet its role remains controversial. Although allogeneic SCT is possibly the only curative treatment and can induce ...

Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities In this retrospective study ...

Patients with the following criteria were included for analysis: (1) Haplo-SCT from 2010 to 2014 in two centers (Institut Paoli Calmettes, Marseille, France; Humanitas Cancer Center, Rozzano, Italy); ...